Form 8-K - Current report:
SEC Accession No. 0000059478-22-000233
Filing Date
2022-10-12
Accepted
2022-10-12 16:08:43
Documents
13
Period of Report
2022-10-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K lly-20221012.htm   iXBRL 8-K 70687
  Complete submission text file 0000059478-22-000233.txt   325778

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20221012.xsd EX-101.SCH 4621
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20221012_def.xml EX-101.DEF 20314
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20221012_lab.xml EX-101.LAB 43455
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20221012_pre.xml EX-101.PRE 21542
7 EXTRACTED XBRL INSTANCE DOCUMENT lly-20221012_htm.xml XML 31389
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 221306944
SIC: 2834 Pharmaceutical Preparations